Patents by Inventor Rob De Vreese

Rob De Vreese has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LIQUID COBALT RESINATE COMPOSITIONS AND METHODS OF PREPARING THE SAME
    Publication number: 20250034358
    Abstract: The present invention provides liquid cobalt resinate compositions as a liquid composition for use in auto-oxidizable coatings or as accelerator in unsaturated polyester resins, comprising: i. cobalt resinate, in an amount of 0.5 to 6.0 wt. % cobalt, relative to the total weight of said liquid composition; ii. one or more antioxidants in an amount of 0.1 to 2.5 wt. %, relative to the total weight of said liquid composition; and iii. one or more organic solvents, in an amount of 25 to 90 wt. %, relative to the total weight of said liquid composition.
    Type: Application
    Filed: December 5, 2022
    Publication date: January 30, 2025
    Inventors: Carl VERCAEMST, Rob DE VREESE, Jan DECAT
  • NOVEL BISPIDONE LIGANDS AND TRANSITION METAL COMPLEXES THEREOF
    Publication number: 20240254126
    Abstract: The present invention provides novel bispidone ligands and transition metal complexes thereof, especially iron and manganese complexes thereof. Furthermore, the present invention also relates to the use of said bispidone ligands and complexes thereof as a siccative agent in curable liquid compositions.
    Type: Application
    Filed: July 8, 2022
    Publication date: August 1, 2024
    Inventors: Carl VERCAEMST, Rob DE VREESE
  • Selective HDAC6 inhibitors and uses thereof
    Patent number: 9993459
    Abstract: The present invention relates to selective Histone deacetylase 6 (HDAC6) inhibitors and compositions containing the same. Methods of treating diseases and conditions wherein inhibition of HDAC6 provides a benefit, like a cell proliferative disease, an autoimmune or inflammatory disorder, a neurodegenerative disease, or a combination thereof, also are disclosed.
    Type: Grant
    Filed: January 7, 2016
    Date of Patent: June 12, 2018
    Assignee: Universiteit Gent
    Inventors: Rob De Vreese, Matthias D'Hooghe
  • SELECTIVE HDAC6 INHIBITORS AND USES THEREOF
    Publication number: 20170360748
    Abstract: The present invention relates to selective Histone deacetylase 6 (HDAC6) inhibitors and compositions containing the same. Methods of treating diseases and conditions wherein inhibition of HDAC6 provides a benefit, like a cell proliferative disease, an autoimmune or inflammatory disorder, a neurodegenerative disease, or a combination thereof, also are disclosed.
    Type: Application
    Filed: January 7, 2016
    Publication date: December 21, 2017
    Applicant: Universiteit Gent
    Inventors: Rob De Vreese, Matthias D'Hooghe
  • HDAC6 inhibitors and uses thereof
    Patent number: 9586973
    Abstract: Histone deacetylases 6 (HDAC6) inhibitors and compositions containing the same. Methods of treating diseases and conditions wherein inhibition of HDAC6 provides a benefit, like a cell proliferative disease, an autoimmune or inflammatory disorder, a neurodegenerative disease, a viral disease, malaria, or a combination thereof.
    Type: Grant
    Filed: September 18, 2015
    Date of Patent: March 7, 2017
    Assignee: Universiteit Gent
    Inventors: Marc Bracke, Matthias D'hooghe, Rob De Vreese
  • HDAC6 INHIBITORS AND USES THEREOF
    Publication number: 20160009730
    Abstract: Histone deacetylases 6 (HDAC6) inhibitors and compositions containing the same. Methods of treating diseases and conditions wherein inhibition of HDAC6 provides a benefit, like a cell proliferative disease, an autoimmune or inflammatory disorder, a neurodegenerative disease, a viral disease, malaria, or a combination thereof.
    Type: Application
    Filed: September 18, 2015
    Publication date: January 14, 2016
    Inventors: Marc Bracke, Matthias D'Hooghe, Rob De Vreese